Thymoma: A focus on current therapeutic management

Journal of Thoracic Oncology

Volumn 4, Issue 1, 2009, Pages 119-126

  Girard, Nicolas ^a   Mornex, Françoise ^a,d   Van Houtte, Paul ^b   Cordier, Jean François ^a   Van Schil, Paul ^c  

^a UNIVERSITÉ DE LYON   (France)

^b JULES BORDET INSTITUTE   (Belgium)

^c Université Libre de Bruxelles ^*  (Belgium)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Chemotherapy; Radiotherapy; Surgery; Thymoma

Indexed keywords

CISPLATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEFITINIB; IFOSFAMIDE; IMATINIB; METHYLPREDNISOLONE; OCTREOTIDE; PREDNISONE; VINCRISTINE;

AUTOIMMUNE DISEASE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; ENDOSCOPIC SURGERY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INOPERABLE CANCER; LOBECTOMY; LUNG FIBROSIS; LUNG RESECTION; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MYASTHENIA GRAVIS; PERICARDITIS; PLEURA TUMOR; PNEUMONIA; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PURE RED CELL ANEMIA; RADIATION DOSE; RADIATION INJURY; RECURRENT CANCER; REVIEW; ROBOTICS; STERNOTOMY; STIFF MAN SYNDROME; SURGICAL APPROACH; THORAX SURGERY; THYMOMA; THYMUS HYPERPLASIA; TREATMENT INDICATION; TREATMENT RESPONSE;

HUMANS; THYMOMA; THYMUS NEOPLASMS;

EID: 61549096592     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31818e105c     Document Type: Review

References (69)

1. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest 2006; 129:174-181.
2. Travis WB, Brambilla A, Muller-Hermelinck HK, Harris CC. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
3. Chalabreysse L, Roy P, Cordier JF, et al. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002;26: 1605-1611.
4. Okumura M, Miyoshi S, Fujii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 2001;25:103-110.
5. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60:908-913.
6. Bretel JJ. Staging and preliminary results of the Thymic Tumour Study Group. In Sarrazin, R, Vrousos C, Vincent F, (Eds.), 7th cancer research workshop. Basel (Swiss): Karger, 1989.
7. Levasseur P, Menestrier M, Gaud C, et al. Thymomas and associated diseases. Apropos of a series of 255 surgically treated thymomas. Rev Mal Respir 1988;5:173-178.
8. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48:2485-2492.
9. Murakawa T, Nakajima J, Kohno T, et al. Results from surgical treatment for thymoma. 43 years of experience. Jpn J Thorac Cardiovasc Surg 2000;48:89-95.
10. Myojin M, Choi NC, Wright CD, et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000;46:927-933.
11. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopath-ologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-1140.
12. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 2002;94:1405-1413.
13. Mornex F, Resbeut M, Richaud P, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 1995;32:651-659.
14. Regnard JF, Zinzindohoue F, Magdeleinat P, et al. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997;64:1593- 1598.
15. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999;230:562-572.
16. Cowen D, Richaud P, Mornex F, et al. Thymoma: results of a multi-centric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 1995;34:9-16.
17. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classification of thymoma. Cancer 1991;68:1984-1987.
18. Srirajaskanthan R, Toubanakis C, Dusmet M, Caplin ME. A review of thymic tumours. Lung Cancer 2008;60:4-13.
19. Sonett JR. Thymectomy for myasthenia gravis: optimal approach. In Ferguson MK, (Ed.), Difficult decisions in thoracic surgery. An evidence-based approach. Chapter 57. Berlin: Springer, 2007. Pp. 469-473.
20. Zielinski M, Kuzdzal J, Szlubowski A, Soja J. Transcervical-subxi-phoid- videothoracoscopic "maximal" thymectomy-operative technique and early results. Ann Thorac Surg 2004;78:404-410.
21. Bodner J, Wykypiel H, Greiner A, et al. Early experience with robot-assisted surgery for mediastinal masses. Ann Thorac Surg 2004;78:259-266.
22. Rea F, Marulli G, Bortolotti L, et al. Experience with the "da Vinci" robotic system for thymectomy in patients with myasthenia gravis: report of 33 cases. Ann Thorac Surg 2006;81:455-459.
23. Ruckert JC, Ismail M, Swierzy M, et al. Thoracoscopic thymectomy with the da Vinci robotic system for myasthenia gravis. Ann N Y Acad Sci 2008;1132:329-335.
24. Cakar F, Werner P, Augustin F, et al. A comparison of outcomes after robotic and open extended thymectomy for myasthenia gravis. Eur J Cardiothorac Surg 2007;31:501-505.
25. Uematsu M, Yoshida H, Kondo M, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 1996;35:357-360.
26. Arriagada R, Bretel JJ, Caillaud JM, et al. Invasive carcinoma of the thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 1984;20:69-74.
27. Ciernik IF, Meier U, Lütolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994;12:1484-1490.
28. Urgesi A, Monetti U, Rossi G, et al. Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol 1992;24:221-225.
29. Bretti S, Berruti A, Loddo C, et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer 2004;44:69-77.
30. Akaogi E, Ohara K, Mitsui K, et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol 1996;63:17-22.
31. Bonomi PD, Finkelstein D, Aisner S, Ettinger D. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993;16:342-345.
32. Highley MS, Underhill CR, Parnis FX, et al. Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999;17:2737-2744.
33. Giaccone G, Ardizzoni A, Kirkpatrick A, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996;14:814-820.
34. Loehrer PJ Sr, Kim K, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12:1164-1168.
35. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy of invasive thymoma. J Clin Oncol 1990;8:1419-1423.
36. Loehrer PJ Sr, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91: 2010-2015.
37. Giaccone G, Wilmink H, Paul MA, van der Valk P. Systemic treatment of malignant thymoma: a decade experience at a single institution. Am J Clin Oncol 2006;29:336-344.
38. Loehrer PJ Sr, Wang W, Johnson DH, et al.; Eastern Cooperative Oncology Group Phase II Trial. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 2004;22:293-299.
39. Henley JD, Koukoulis GK, Loehrer PJ Sr. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002;128:167-170.
40. Kurup A, Burns M, Dropcho S, et al. Phase II study of gefitinib treatment in advanced thymic malignancies. J Clin Oncol, ASCO Annual Meeting Proceedings. 2005;23:7068 [Abstract].
41. Strobel P, Hartmann M, Jakob A, et al. Thymic carcinoma with over-expression of mutated KIT and the response to imatinib. N Engl J Med 2004;350:2625-2626.
42. Yamaguchi H, Soda H, Kitazaki T, et al. Thymic carcinoma with epidermal growth factor receptor gene mutations. Lung Cancer 2006; 52:261-262.
43. Yarom N, Zissin R, Apter S, et al. Rebound thymic enlargement on CT in adults. Int J Clin Pract 2007;61:562-568.
44. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-884.
45. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-1641.
46. Zhang H, Lu N, Wang M, et al. Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases. Chin Med J (Engl) 1999;112:136-138.
47. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT, III. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727.
48. Kitami A, Suzuki T, Kamio Y, Suzuki S. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature. Jpn J Clin Oncol 2001;31:601-604.
49. Yagi K, Hirata T, Fukuse T, et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996;61:521-524.
50. Fujino S, Tezuka N, Watarida S, et al. Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion. Ann Thorac Surg 1998;66:263-264.
51. Minato N, Rikitake K, Ohnishi H, et al. Invasive thymoma with intra-caval growth extending and directly invading the right atrium. J Cardiovasc Surg (Torino) 1999;40:915-917.
52. Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006;82:1234-1239.
53. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage un-resectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093- 3099.
54. Berruti A, Borasio P, Gerbino A, et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 1999; 81:841-845.
55. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993;106:543-549.
56. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76:1866-1872.
57. Lucchi M, Melfi F, Dini P, et al. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 2006;1:308-313.
58. Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998;129: 100-104.
59. Yokoi K, Matsuguma H, Nakahara R, et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2007;2:73-78.
60. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991;68:706-713.
61. Oshita F, Kasai T, Kurata T, et al. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results. Jpn J Clin Oncol 1995;25:208-212.
62. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisci-plinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unre-sectable malignant thymomas: final report. Lung Cancer 2004;44:369-379.
63. Masaoka A, Yamakawa Y, Niwa H, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 1996; 62:853-859.
64. de Perrot M, Liu J, Bril V, et al. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg. 2002;74:1658-1662.
65. Kudva GC, Maliekel K, Kim HJ, et al. Thymoma and myotonic dystrophy: successful treatment with chemotherapy and radiation: case report and review of the literature. Chest 2002;121:2061-2063.
66. Iwata T, Inoue K, Mizuguchi S, et al. Thymectomy for paraneoplastic stiff-person syndrome associated with invasive thymoma. J Thorac Cardiovasc Surg 2006;132:196-197.
67. Thompson CA, Steensma DP. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 2006;135:405-407.
68. H. Heyman SR, De Raeve H, Mercelis R, et al. Recurrent myasthenia gravis due to a pleural implant 3 years after radical thymectomy. Ann Thorac Surg 2008;86:299-301.
69. Ströbel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004;22:1501-1509.